Servier signs definitive agreement with Day One Biopharmaceuticals
PureHealth Research launches new natural GLP-1 supplements
PyroGenesis completes plasma torch system for Constellium aluminium furnace project
Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial
Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort
Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM
Thermo Fisher Scientific opens Bay Area cryo-EM Drug Discovery Center
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
iLoF collaborates with Bluepharma to deploy AI-powered Optomics
Akeso agrees clinical trial collaboration with INOVIO
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
Frontage Laboratories acquires Teddy Clinical Research Laboratory in China
Allergy Therapeutics reports positive biomarker data from PROTECT trial
HUTCHMED doses first patient in global trial of ATTC candidate HMPL-A580